{"id":1517,"date":"2020-10-14T14:21:39","date_gmt":"2020-10-14T14:21:39","guid":{"rendered":"https:\/\/www.cebiotex.com\/?page_id=1517"},"modified":"2020-10-19T10:17:27","modified_gmt":"2020-10-19T10:17:27","slug":"luc-marti","status":"publish","type":"page","link":"https:\/\/www.cebiotex.com\/es\/luc-marti\/","title":{"rendered":"Luc Marti"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1517\" class=\"elementor elementor-1517\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"has_eae_slider elementor-section elementor-top-section elementor-element elementor-element-46b7824a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-eae-slider=\"56807\" data-id=\"46b7824a\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"has_eae_slider elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-2083fd3f\" data-eae-slider=\"88283\" data-id=\"2083fd3f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-32ff109c elementor-widget elementor-widget-text-editor\" data-id=\"32ff109c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><\/p>\n<p class=\"wp-block-paragraph\"><strong>PhD, MBM, Chief Operations Officer<\/strong><\/p>\n<p><\/p>\n<p class=\"wp-block-paragraph\">Luc Marti, PhD, MBM, tiene 27 a\u00f1os de experiencia en farmacolog\u00eda de los cuales 15 en desarrollo de f\u00e1rmacos. Ha obtenido 7 autorizaciones para ensayos cl\u00ednicos en 3 indicaciones distintas.<\/p>\n<p>Antes de unirse a Cebiotex como director de operaciones, fue VP Operations I+D en Artax Biopharma (MA, EEAA) desarrollando una terapia para enfermedades autoinmunes hasta la fase cl\u00ednica Ib incluida. En 2005 cofund\u00f3 Genmedica Therapeutics, S.L. cuyo producto, un antidiab\u00e9tico, lleg\u00f3 a fase II.<\/p>\n<p>Luc es Doctor en Farmacolog\u00eda Celular (Inserm, UPS, Toulouse) y tiene un M\u00e1ster en Biotecnology Management (IE Business School, Madrid).<\/p>\n<p><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8cce78c elementor-view-stacked elementor-shape-circle elementor-widget elementor-widget-icon\" data-id=\"8cce78c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<a class=\"elementor-icon\" href=\"https:\/\/www.linkedin.com\/in\/lucmarti\/\">\n\t\t\t<i aria-hidden=\"true\" class=\"fab fa-linkedin\"><\/i>\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"has_eae_slider elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-5d601f2c\" data-eae-slider=\"1990\" data-id=\"5d601f2c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3a381289 elementor-widget elementor-widget-image\" data-id=\"3a381289\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"480\" height=\"300\" src=\"https:\/\/www.cebiotex.com\/wp-content\/uploads\/2020\/10\/luc-cebiotex.jpg\" class=\"attachment-large size-large wp-image-1440\" alt=\"Luc Marti\" srcset=\"https:\/\/www.cebiotex.com\/wp-content\/uploads\/2020\/10\/luc-cebiotex.jpg 480w, https:\/\/www.cebiotex.com\/wp-content\/uploads\/2020\/10\/luc-cebiotex-300x188.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"has_eae_slider elementor-section elementor-top-section elementor-element elementor-element-6326f230 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-eae-slider=\"55903\" data-id=\"6326f230\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"has_eae_slider elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-16b7d5e5\" data-eae-slider=\"37860\" data-id=\"16b7d5e5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-450177e8 elementor-align-center elementor-widget elementor-widget-button\" data-id=\"450177e8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-md\" href=\"https:\/\/www.cebiotex.com\/#equipo\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-caret-left\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Equipo<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>PhD, MBM, Chief Operations Officer Luc Marti, PhD, MBM, tiene 27 a\u00f1os de experiencia en farmacolog\u00eda de los cuales 15 en desarrollo de f\u00e1rmacos. Ha obtenido 7 autorizaciones para ensayos cl\u00ednicos en 3 indicaciones distintas. Antes de unirse a Cebiotex como director de operaciones, fue VP Operations I+D en Artax Biopharma (MA, EEAA) desarrollando una [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1517","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.cebiotex.com\/es\/wp-json\/wp\/v2\/pages\/1517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cebiotex.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cebiotex.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cebiotex.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cebiotex.com\/es\/wp-json\/wp\/v2\/comments?post=1517"}],"version-history":[{"count":11,"href":"https:\/\/www.cebiotex.com\/es\/wp-json\/wp\/v2\/pages\/1517\/revisions"}],"predecessor-version":[{"id":1778,"href":"https:\/\/www.cebiotex.com\/es\/wp-json\/wp\/v2\/pages\/1517\/revisions\/1778"}],"wp:attachment":[{"href":"https:\/\/www.cebiotex.com\/es\/wp-json\/wp\/v2\/media?parent=1517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}